+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Gastroparesis Market and Competitive Landscape - 2022

  • PDF Icon

    Report

  • August 2022
  • Region: United States
  • Fore Pharma
  • ID: 5644723
The report US Gastroparesis Market and Competitive Landscape Highlights - 2022, provides comprehensive insights into Gastroparesis pipeline products, Gastroparesis epidemiology, Gastroparesis market valuations and forecast, Gastroparesis drugs sales and competitive landscape in the US.

The research is classified into seven sections - Gastroparesis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Gastroparesis pipeline: Find out the products in clinical trials for the treatment of Gastroparesis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Gastroparesis epidemiology: Find out the number of patients diagnosed (prevalence) with Gastroparesis in the US
  • Gastroparesis drugs: Identify key products marketed and prescribed for Gastroparesis in the US, including trade name, molecule name, and company
  • Gastroparesis drugs sales: Find out the sales revenues of Gastroparesis drugs in the US
  • Gastroparesis market valuations: Find out the market size for Gastroparesis drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027
  • Gastroparesis drugs market share: Find out the market shares for key Gastroparesis drugs in the US

Benefits of this Research:

The research helps executives to
  • Support monitoring and reporting national Gastroparesis market analysis and sales trends
  • Track competitor drugs sales and market share in the US Gastroparesis market
  • Track competitive developments in Gastroparesis market and present key issues and learnings
  • Synthesize insights for Gastroparesis market and products to drive business performance
  • Answer key business questions about the Gastroparesis market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Gastroparesis products
  • Supports decision making in R&D to long term marketing strategies

Table of Contents

1) Gastroparesis Treatments
2) Gastroparesis Pipeline
3) US Gastroparesis Epidemiology
4) Marketed Drugs for Gastroparesis in US
5) US Gastroparesis Market Size and Forecast
6) US Gastroparesis Products Sales and Forecast
7) US Gastroparesis Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables
1. Gastroparesis Phase 3 Clinical Trials, 2022
2. Gastroparesis Phase 2 Clinical Trials, 2022
3. Gastroparesis Phase 1 Clinical Trials, 2022
4. Gastroparesis Epidemiology, US, 2021 - 2027
5. Marketed Drugs for Gastroparesis, US, 2021
6. Gastroparesis Market Size and Forecast ($), US, 2019 - 2027
7. Gastroparesis Drugs Sales ($), US, 2019 - 2027

List of Figures
1. Gastroparesis Epidemiology, US, 2021 - 2027
2. Gastroparesis Market Size and Forecast ($), US, 2019 - 2027
3. Gastroparesis Drugs Market Share (%), US, 2021